Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Airway Telomere Length in Lung Transplant Recipients.
Mackintosh JA, Yerkovich ST, Tan ME, Samson L, Hopkins PM, Chambers DC. Mackintosh JA, et al. Front Immunol. 2021 Apr 16;12:658062. doi: 10.3389/fimmu.2021.658062. eCollection 2021. Front Immunol. 2021. PMID: 33936089 Free PMC article.
TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis.
Mackintosh JA, Pietsch M, Lutzky V, Enever D, Bancroft S, Apte SH, Tan M, Yerkovich ST, Dickinson JL, Pickett HA, Selvadurai H, Grainge C, Goh NS, Hopkins P, Glaspole I, Reynolds PN, Wrobel J, Jaffe A, Corte TJ, Chambers DC. Mackintosh JA, et al. BMJ Open Respir Res. 2021 Dec;8(1):e001127. doi: 10.1136/bmjresp-2021-001127. BMJ Open Respir Res. 2021. PMID: 34857525 Free PMC article. Clinical Trial.
Genomic lung allograft surveillance-is it primer time?
Mackintosh JA, Chambers DC. Mackintosh JA, et al. J Heart Lung Transplant. 2022 Apr;41(4):467-469. doi: 10.1016/j.healun.2022.01.016. Epub 2022 Jan 23. J Heart Lung Transplant. 2022. PMID: 35184968 No abstract available.
Deep Learning-based Outcome Prediction in Progressive Fibrotic Lung Disease Using High-Resolution Computed Tomography.
Walsh SLF, Mackintosh JA, Calandriello L, Silva M, Sverzellati N, Larici AR, Humphries SM, Lynch DA, Jo HE, Glaspole I, Grainge C, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Zappala C, Keir G, Cooper WA, Mahar AM, Ellis S, Wells AU, Corte TJ. Walsh SLF, et al. Among authors: mackintosh ja. Am J Respir Crit Care Med. 2022 Oct 1;206(7):883-891. doi: 10.1164/rccm.202112-2684OC. Am J Respir Crit Care Med. 2022. PMID: 35696341
Towards truly 'idiopathic' pulmonary fibrosis.
Mackintosh JA, Chambers DC. Mackintosh JA, et al. Respirology. 2022 Sep;27(9):682-683. doi: 10.1111/resp.14320. Epub 2022 Jun 28. Respirology. 2022. PMID: 35764391 Free article. No abstract available.
Quantitative computed tomography predicts outcomes in idiopathic pulmonary fibrosis.
Humphries SM, Mackintosh JA, Jo HE, Walsh SLF, Silva M, Calandriello L, Chapman S, Ellis S, Glaspole I, Goh N, Grainge C, Hopkins PMA, Keir GJ, Moodley Y, Reynolds PN, Walters EH, Baraghoshi D, Wells AU, Lynch DA, Corte TJ. Humphries SM, et al. Among authors: mackintosh ja. Respirology. 2022 Dec;27(12):1045-1053. doi: 10.1111/resp.14333. Epub 2022 Jul 25. Respirology. 2022. PMID: 35875881 Free PMC article.
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Solomon JJ, et al. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. Lancet Respir Med. 2023. PMID: 36075242 Clinical Trial.
41 results